K-beauty has always known how to sell glow but in 2025, it sold scale, science and serious profits. South Korean beauty tech firm APR, the parent company of Medicube, has just crossed a milestone most beauty brands only dream of: ₩1.53 trillion ($1 billion) in annual revenue, marking its strongest year since launching in 2014.
APR reported operating profit of ₩365.4 billion, up 198% year-on-year, with margins hitting a record 24%. In Q4 alone, revenue topped ₩547.6 billion, the first time the company has crossed the ₩500 billion quarterly mark. The standout star remains the Medicube brand, and international expansion has been key. APR entered major offline retailers including Ulta Beauty and Japan’s Don Quijote, helping overseas revenue surge 207%vto ₩1.2 trillion.
Overseas sales now account for 80% of total revenue – a dramatic leap from just 40% in 2023 – with the US becoming APR’s biggest market at 37% of sales. APR now has its sights set on ₩2 trillion in revenue – proof that beauty tech isn’t niche anymore. It’s big business.
Our Medicube Beauty-Tech & Scientific Skincare Must-Haves:
Medicube Age-R Booster Pro Ex Pink
Medicube One Day Exosome Shot Pore Ampoule 2000 30ml
Medicube Age-r LED Booster Pro Black
Medicube Zero Pore Pad 2.0
Salmon DNA PDRN Pink Collagen Jelly Gel Mask
Some of the products and services featured in this article may be from our affiliate partners, which means we may earn a small commission if you make a purchase through these links — at no extra cost to you. Our editorial team only spotlights what we genuinely love and think you will, too.
Leave a Comment